Synergistic induction of the Fas (CD95) ligand promoter by Max and NFκB in human non-small lung cancer cells

Lade...
Vorschaubild
Dateien
Wiener_142854.pdf
Wiener_142854.pdfGröße: 456.64 KBDownloads: 314
Datum
2004
Autor:innen
Wiener, Zoltan
Ontsouka, Edgar C.
Jakob, Sabine
Torgler, Ralph
Falus, Andras
Mueller, Christoph
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Experimental Cell Research. 2004, 299(1), pp. 227-235. ISSN 0014-4827. Available under: doi: 10.1016/j.yexcr.2004.05.031
Zusammenfassung

Fas (CD95/APO-1) ligand is a member of the Tumor Necrosis Factor family and a potent inducer of apoptosis. Fas ligand is expressed in activated T cells and represents a major cytotoxic effector mechanism by which T cells kill their target cells. Activation-induced Fas ligand expression in T cells is under the stringent control of various transcription factors, including nuclear factor κB (NFκB) and c-Myc/Max. There is accumulating evidence that Fas ligand is also expressed by various non-hematopoietic tumor cells, however, little is known about Fas ligand regulation in tumor cells. In this study, we have analyzed the regulation of the Fas ligand gene promoter induction in two non-small cell lung cancer cell lines, with a major focus on the role of the c-Myc/Max transcription factor. Our results revealed that inhibition of c-Myc/Max did not substantially reduce basal levels of Fas ligand promoter activity, nor did overexpression of c-Myc significantly induce promoter activity. In contrast, we observed that overexpression of Max resulted in a marked increase in basal promoter activity and synergistically enhanced phorbolester- and doxorubicin-induced NFκB-mediated Fas ligand promoter activity. These results were confirmed by analyzing endogenous Fas ligand transcription. We conclude that high levels of Max and stress-induced NFκB activation may result in elevated expression of Fas ligand in human lung cancer cells and possibly contribute to Fas ligand-associated immune escape mechanisms.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Apoptosis, Transcription, Signaling, Tumor necrosis factor family, Tumor cells
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690WIENER, Zoltan, Edgar C. ONTSOUKA, Sabine JAKOB, Ralph TORGLER, Andras FALUS, Christoph MUELLER, Thomas BRUNNER, 2004. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFκB in human non-small lung cancer cells. In: Experimental Cell Research. 2004, 299(1), pp. 227-235. ISSN 0014-4827. Available under: doi: 10.1016/j.yexcr.2004.05.031
BibTex
@article{Wiener2004-09-10Syner-14285,
  year={2004},
  doi={10.1016/j.yexcr.2004.05.031},
  title={Synergistic induction of the Fas (CD95) ligand promoter by Max and NFκB in human non-small lung cancer cells},
  number={1},
  volume={299},
  issn={0014-4827},
  journal={Experimental Cell Research},
  pages={227--235},
  author={Wiener, Zoltan and Ontsouka, Edgar C. and Jakob, Sabine and Torgler, Ralph and Falus, Andras and Mueller, Christoph and Brunner, Thomas}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/14285">
    <dcterms:title>Synergistic induction of the Fas (CD95) ligand promoter by Max and NFκB in human non-small lung cancer cells</dcterms:title>
    <dcterms:bibliographicCitation>Publ. in: Experimental Cell Research ; 299 (2004), 1. - S. 227-235</dcterms:bibliographicCitation>
    <dc:creator>Torgler, Ralph</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14285/2/Wiener_142854.pdf"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-20T14:22:56Z</dc:date>
    <dcterms:issued>2004-09-10</dcterms:issued>
    <dc:creator>Brunner, Thomas</dc:creator>
    <dc:creator>Falus, Andras</dc:creator>
    <dc:creator>Mueller, Christoph</dc:creator>
    <dc:contributor>Brunner, Thomas</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/14285/2/Wiener_142854.pdf"/>
    <dc:creator>Wiener, Zoltan</dc:creator>
    <dcterms:abstract xml:lang="eng">Fas (CD95/APO-1) ligand is a member of the Tumor Necrosis Factor family and a potent inducer of apoptosis. Fas ligand is expressed in activated T cells and represents a major cytotoxic effector mechanism by which T cells kill their target cells. Activation-induced Fas ligand expression in T cells is under the stringent control of various transcription factors, including nuclear factor κB (NFκB) and c-Myc/Max. There is accumulating evidence that Fas ligand is also expressed by various non-hematopoietic tumor cells, however, little is known about Fas ligand regulation in tumor cells. In this study, we have analyzed the regulation of the Fas ligand gene promoter induction in two non-small cell lung cancer cell lines, with a major focus on the role of the c-Myc/Max transcription factor. Our results revealed that inhibition of c-Myc/Max did not substantially reduce basal levels of Fas ligand promoter activity, nor did overexpression of c-Myc significantly induce promoter activity. In contrast, we observed that overexpression of Max resulted in a marked increase in basal promoter activity and synergistically enhanced phorbolester- and doxorubicin-induced NFκB-mediated Fas ligand promoter activity. These results were confirmed by analyzing endogenous Fas ligand transcription. We conclude that high levels of Max and stress-induced NFκB activation may result in elevated expression of Fas ligand in human lung cancer cells and possibly contribute to Fas ligand-associated immune escape mechanisms.</dcterms:abstract>
    <dc:language>eng</dc:language>
    <dc:contributor>Falus, Andras</dc:contributor>
    <dc:contributor>Mueller, Christoph</dc:contributor>
    <dc:contributor>Jakob, Sabine</dc:contributor>
    <dc:contributor>Ontsouka, Edgar C.</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14285"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Jakob, Sabine</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-10-20T14:22:56Z</dcterms:available>
    <dc:creator>Ontsouka, Edgar C.</dc:creator>
    <dc:contributor>Torgler, Ralph</dc:contributor>
    <dc:contributor>Wiener, Zoltan</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:rights>terms-of-use</dc:rights>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Diese Publikation teilen